Moberg Pharma AB (publ)
Moberg Pharma AB (publ), headquartered in Sweden, is a prominent player in the pharmaceutical industry, specialising in innovative healthcare solutions. Founded in 2006, the company has made significant strides in developing and commercialising products that address unmet medical needs, particularly in the fields of dermatology and pain management. With a strong focus on proprietary formulations, Moberg Pharma's core products include topical treatments that leverage unique delivery systems, setting them apart in a competitive market. The company has established a solid market position, recognised for its commitment to quality and efficacy. Notable achievements include successful partnerships and a growing international presence, particularly in Europe and North America, underscoring its role as a leader in the pharmaceutical landscape.
DitchCarbon Score
How does Moberg Pharma AB (publ)'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Moberg Pharma AB (publ)'s score of 26 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Moberg Pharma AB (publ)'s reported carbon emissions
Moberg Pharma AB (publ), headquartered in Sweden, currently does not have any available carbon emissions data or specific reduction targets outlined in their climate commitments. As such, there are no reported figures for their Scope 1, 2, or 3 emissions. The absence of emissions data suggests that the company may still be in the early stages of formalising its climate strategy or reporting practices. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to set science-based targets to reduce their carbon footprint. While Moberg Pharma has not disclosed any specific initiatives or commitments, the industry trend indicates a growing emphasis on environmental responsibility and climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Moberg Pharma AB (publ) is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
